z-logo
open-access-imgOpen Access
Cancer care and public health policy evaluations in France: Usefulness of the national cancer cohort
Author(s) -
PhilippeJean Bousquet,
D. Lefeuvre,
Philippe Tuppin,
Marc Karim Bendiane,
M. Rocchi,
Elsa Bouée-Benhamiche,
Jérôme Viguier,
Christine Le Bihan-Benjamin
Publication year - 2018
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0206448
Subject(s) - medicine , cancer , cohort , context (archaeology) , health care , population , family medicine , colorectal cancer , cancer registry , breast cancer , environmental health , economic growth , paleontology , economics , biology
Background In the context of the national Cancer Plans of France that have changed the healthcare landscape, it has become necessary to better document and assess the related actions, and to promote research and understanding. The national cancer cohort, an exhaustive population-based cohort, was set up on the basis of the National Health Data System (SNDS) by the French National Cancer Institute. Objectives The aim is to describe the French national cancer cohort. Methods All people living in France (67 million population) with universal insurance coverage and diagnosed, treated or followed up for a cancer, such as survivors, are included and will be followed up for 25 years. It contains all healthcare consumptions and reimbursements ( i . e . hospitalization, outpatient care, medication…) since 2010. Every year, around 650 000 new cases are included. Results From 2010 to 2015, 6.2 million subjects have been included. Most subjects were entered in 2010, in 2015 it concerned 0.6 million. In 2015, the median age was 65 [54–76]; 51% were women. The primary cancer organ could be attributed with certitude to 87% of the people. The most frequent locations were skin (16%), breast (15%), prostate (12%), colon-rectum (11%) and lung (9%). In 2015, 40% of included subjects underwent surgery for cancer, 16% chemotherapy at hospital and 11% at least one session of radiotherapy. Conclusion Based on SNDS, the cancer cohort has been designed to study cancer care use in the short-, medium- and long-term, and evaluate healthcare and public health policies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here